Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply
Abstract
Author
Citations
Altmetric:
Date
2018
Type
Correspondence
Subject
Risk assessment, Attention deficit disorder with hyperactivity, Drug therapy
Collections
Citation
Cipriani, A., Adamo, N., Giovane, C. D., Coghill, D., Banaschewski, T., Hollis, C. P., Zuddas, A., Simonoff, E. & Cortese, S. (2018). Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply. The Lancet Psychiatry, 5 (11), pp.871-873.